These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32444894)

  • 1. Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study.
    Keats MR; Cui Y; DeClercq V; Grandy SA; Sweeney E; Dummer TJB
    Support Care Cancer; 2021 Feb; 29(2):713-723. PubMed ID: 32444894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypharmacy and patterns of prescription medication use among cancer survivors.
    Murphy CC; Fullington HM; Alvarez CA; Betts AC; Lee SJC; Haggstrom DA; Halm EA
    Cancer; 2018 Jul; 124(13):2850-2857. PubMed ID: 29645083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden.
    Gallacher KI; Batty GD; McLean G; Mercer SW; Guthrie B; May CR; Langhorne P; Mair FS
    BMC Med; 2014 Oct; 12():151. PubMed ID: 25280748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study.
    Hanlon P; Nicholl BI; Jani BD; McQueenie R; Lee D; Gallacher KI; Mair FS
    BMJ Open; 2018 Jan; 8(1):e018404. PubMed ID: 29332840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypharmacy and prescription medication use in a population-based sample of adolescent and young adult cancer survivors.
    Betts AC; Murphy CC; Shay LA; Balasubramanian BA; Markham C; Allicock M
    J Cancer Surviv; 2023 Aug; 17(4):1149-1160. PubMed ID: 34997910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study.
    Nguyen TN; Ngangue P; Haggerty J; Bouhali T; Fortin M
    Fam Pract; 2019 Nov; 36(6):706-712. PubMed ID: 31104072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total burden of disease in cancer patients at diagnosis-a Danish nationwide study of multimorbidity and redeemed medication.
    Loeppenthin K; Dalton SO; Johansen C; Andersen E; Christensen MB; Pappot H; Petersen LN; Thisted LB; Frølich A; Mortensen CE; Lassen U; Ørsted J; Bidstrup PE
    Br J Cancer; 2020 Sep; 123(6):1033-1040. PubMed ID: 32632149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-life depression and the association with multimorbidity and polypharmacy: a cross-sectional study.
    Holvast F; van Hattem BA; Sinnige J; Schellevis F; Taxis K; Burger H; Verhaak PFM
    Fam Pract; 2017 Sep; 34(5):539-545. PubMed ID: 28369380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between multimorbidity and depression among breast cancer survivors within the UK Biobank cohort: a cross-sectional study.
    Foster M; Niedzwiedz CL
    BMC Cancer; 2021 May; 21(1):650. PubMed ID: 34058985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypharmacy and medication fill nonadherence in a population-based sample of adolescent and young adult cancer survivors, 2008-2017.
    Betts AC; Murphy CC; Shay LA; Balasubramanian BA; Markham C; Roth ME; Allicock M
    J Cancer Surviv; 2023 Dec; 17(6):1688-1697. PubMed ID: 36346577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimorbidity patterns in relation to polypharmacy and dosage frequency: a nationwide, cross-sectional study in a Japanese population.
    Aoki T; Yamamoto Y; Ikenoue T; Onishi Y; Fukuhara S
    Sci Rep; 2018 Feb; 8(1):3806. PubMed ID: 29491441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in multimorbidity and polypharmacy trends: A repeated cross-sectional study of older adults in Ontario, Canada.
    Maxwell CJ; Mondor L; Pefoyo Koné AJ; Hogan DB; Wodchis WP
    PLoS One; 2021; 16(4):e0250567. PubMed ID: 33901232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypharmacy, limited activity, fatigue and insomnia are the most frequent symptoms and impairments in older hematological cancer survivors (70+): Findings from a register-based study on physical and mental health.
    Götze H; Köhler N; Taubenheim S; Lordick F; Mehnert A
    J Geriatr Oncol; 2019 Jan; 10(1):55-59. PubMed ID: 29880406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying and characterizing cancer survivors in the US primary care safety net.
    Hoopes M; Schmidt T; Huguet N; Winters-Stone K; Angier H; Marino M; Shannon J; DeVoe J
    Cancer; 2019 Oct; 125(19):3448-3456. PubMed ID: 31174231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study.
    Zhao Y; Wang J; Zhu X; Zhang X; Zhang Y; Zhang W; Dong Y
    BMC Geriatr; 2023 Jul; 23(1):423. PubMed ID: 37434147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacy and medication use by cancer history in a nationally representative group of adults in the USA, 2003-2014.
    Hsu CD; Nichols HB; Lund JL
    J Cancer Surviv; 2022 Jun; 16(3):659-666. PubMed ID: 34032998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypharmacy Among Privately Insured Adults with Cerebral Palsy: A Retrospective Cohort Study.
    Whitney DG; Schmidt M; Peterson MD; Haapala H
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1153-1161. PubMed ID: 32857655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genetic model for multimorbidity in young adults.
    Malecki SL; Van Mil S; Graffi J; Breetvelt E; Corral M; Boot E; Chow EWC; Sanches M; Verma AA; Bassett AS
    Genet Med; 2020 Jan; 22(1):132-141. PubMed ID: 31363180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the Extent of Polypharmacy and its Association With Health Service Utilization Among Persons With Cancer and Multimorbidity: A Population-Based Retrospective Cohort Study in Ontario, Canada.
    Dean T; Koné A; Martin L; Armstrong J; Sirois C
    J Pharm Pract; 2024 Feb; 37(1):35-46. PubMed ID: 35861340
    [No Abstract]   [Full Text] [Related]  

  • 20. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study.
    Lopez-Rodriguez JA; Rogero-Blanco E; Aza-Pascual-Salcedo M; Lopez-Verde F; Pico-Soler V; Leiva-Fernandez F; Prados-Torres JD; Prados-Torres A; Cura-González I;
    PLoS One; 2020; 15(8):e0237186. PubMed ID: 32785232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.